[Psychotic episode caused by prevention of malaria with mefloquine. A case report].
We report on a 41 year old woman, who after 750 mg mefloquine, a newer antimalarial agent, developed a psychosis with dizziness, confusion and delusions. The symptoms were more intensive and remained longer than hitherto reported in the literature. A total of 23 patients are known to have had psychiatric adverse effects under mefloquine. Psychotic episodes are undoubtedly though rarely associated with the intake of mefloquine.
Folkerts
H
H
Klinik für Psychiatrie, Westfälischen Wilhelms-Universität Münster.
Kuhs
H
H
D000328:Adult; D005260:Female; D006212:Hallucinations / Q000139:chemically induced* / Q000188:drug therapy / Q000523:psychology; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D015767:Mefloquine / Q000008:administration & dosage / Q000009:adverse effects*; D010464:Perazine / Q000008:administration & dosage; D011605:Psychoses, Substance-Induced / Q000188:drug therapy / Q000209:etiology* / Q000523:psychology; D012008:Recurrence; D012307:Risk Factors
D010464:Perazine; D006220:Haloperidol; D015767:Mefloquine
Psychotische Episode infolge Malariaprophylaxe mit Mefloquin. Eine kasuistische Mitteilung.